Export Controls on pharmaceuticals: testing, NOC and labelling conditions govern permitted exports and restricted items. Export controls under ITC (HS) 2022 Chapter 30 set classification and exclusion rules, define immunological products, and limit heading 3006 to specified sterile surgical and clinical items. Key operational conditions require Certificates of Analysis from designated laboratories for cough syrup unless the manufacturing plant is approved by certain foreign regulators; No Objection Certificates for human biological materials depending on regulatory coverage; heavy metal labelling or testing certification for herbal medicines; and compliance with wildlife/CITES restrictions for extracts and derivatives.
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Export Controls on pharmaceuticals: testing, NOC and labelling conditions govern permitted exports and restricted items.
Export controls under ITC (HS) 2022 Chapter 30 set classification and exclusion rules, define immunological products, and limit heading 3006 to specified sterile surgical and clinical items. Key operational conditions require Certificates of Analysis from designated laboratories for cough syrup unless the manufacturing plant is approved by certain foreign regulators; No Objection Certificates for human biological materials depending on regulatory coverage; heavy metal labelling or testing certification for herbal medicines; and compliance with wildlife/CITES restrictions for extracts and derivatives.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.
TaxTMI 
of 
Join Channel
TaxTMI 
